CENTRAL ESOURCE

Serial Number 99230404
661

Registration Progress

Application Filed
Jun 12, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Feb 01, 2026 42 days

Trademark Image

CENTRAL ESOURCE

Basic Information

Serial Number
99230404
Filing Date
June 12, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Dec 19, 2025
Application
Pending
Classes
042

Rights Holder

CRIO Inc.

03
Address
Suite 605, PMB 32876
68 Harrison Avenue
Boston, MA 02111

Ownership History

CRIO Inc.

Original Applicant
03
Boston, MA

Legal Representation

Attorney
Gregory Bernabeo

USPTO Deadlines

Next Deadline
42 days remaining
Non-Final Action E-Mailed
Due Date
February 01, 2026
Extension Available
Until May 01, 2026

Application History

10 events
Date Code Type Description Documents
Dec 19, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 19, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 19, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 1, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 1, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 1, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 31, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 19, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 12, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 12, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Software as a service (SAAS) services featuring software for clinical trial management; Software as a service (SAAS) services featuring software for financial management for clinical trials; Software as a service (SAAS) services featuring software for recruitment of patients for clinical trials; Software as a service (SAAS) services featuring software for management of patients during clinical trials; Software as a service (SAAS) services featuring software for providing centralized oversight for multiple clinical trial sites and studies, and reporting for clinical trials
First Use Anywhere: May 31, 2025
First Use in Commerce: May 31, 2025

Additional Information

Pseudo Mark
CENTRAL E SOURCE

Classification

International Classes
042